Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal dataYanzheng Zou, Peng Huang, Linna Jia et al.|BMC Cancer|2023Cited by 13
Epidemiology of acute hepatitis C and hepatitis C virus-related cirrhosis in reproductive-age women, 1990–2019: An analysis of the Global Burden of Disease studyYanzheng Zou, Peng Huang, A‐Mei Zhang et al.|Journal of Global Health|2024Cited by 10
Repeated Measurement of FIB-4 to Predict Long-Term Risk of HCC Development Up to 10 Years After SVRYanzheng Zou, Peng Huang, Meiling Zhang et al.|Journal of Hepatocellular Carcinoma|2022Cited by 9
Evaluating short-term and long-term liver fibrosis improvement in hepatitis C patients after DAA treatmentYifan Wang, Peng Huang, Yanzheng Zou et al.|Journal of Biomedical Research|2024Cited by 3
Trajectories of De Ritis ratio with risk of hepatocellular carcinoma and liver-related mortality following direct-acting antivirals for HCV: a retrospective longitudinal study up to 10 yearsLinna Jia, Peng Huang, Yanzheng Zou et al.|Carcinogenesis|2022Cited by 2